Access Route and Clinical Outcomes After Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome Undergoing Invasive Treatment Strategy.

MLA

Hemetsberger, Rayyan, et al. “Access Route and Clinical Outcomes After Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome Undergoing Invasive Treatment Strategy.” Cardiovascular Revascularization Medicine : Including Molecular Interventions, vol. 41, Aug. 2022, pp. 122–28. EBSCOhost, https://doi.org/10.1016/j.carrev.2021.12.029.

APA

Hemetsberger, R., Richardt, G., Lahu, S., Valina, C., Menichelli, M., Abdelghani, M., Wöhrle, J., Toelg, R., Witzenbichler, B., Mankerious, N., Liebetrau, C., Bernlochner, I., Hamm, C. W., Allali, A., Joner, M., Fusaro, M., Xhepa, E., Hapfelmeier, A., Kufner, S., … Cassese, S. (2022). Access Route and Clinical Outcomes After Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome Undergoing Invasive Treatment Strategy. Cardiovascular Revascularization Medicine : Including Molecular Interventions, 41, 122–128. https://doi.org/10.1016/j.carrev.2021.12.029

Chicago

Hemetsberger, Rayyan, Gert Richardt, Shqipdona Lahu, Christian Valina, Maurizio Menichelli, Mohammad Abdelghani, Jochen Wöhrle, et al. 2022. “Access Route and Clinical Outcomes After Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome Undergoing Invasive Treatment Strategy.” Cardiovascular Revascularization Medicine : Including Molecular Interventions 41 (August): 122–28. doi:10.1016/j.carrev.2021.12.029.